VIGADEXA Gel Compared to VIGADEXA Solution Following Cataract Surgery
Status:
Withdrawn
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare VIGADEXA (moxifloxacin 0.5%/dexamethasone phosphate
0.075%) ophthalmic gel to VIGADEXA (moxifloxacin 0.5%/dexamethasone phosphate 0.1%)
ophthalmic solution in the prevention of postoperative inflammation and infection.